1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitors

Bioorg Med Chem Lett. 2004 Jun 21;14(12):3217-20. doi: 10.1016/j.bmcl.2004.03.105.

Abstract

The synthesis and kinase inhibitory activity of a series of novel 1,7-annulated indolocarbazoles 6 and 16 is described. These compounds exhibited potent inhibitory activity against cyclin-dependent kinase 4 and good antiproliferative activity in a human colon carcinoma cell line.

MeSH terms

  • Carbazoles / chemistry*
  • Carbazoles / pharmacology
  • Cyclin D1 / antagonists & inhibitors
  • Cyclin D1 / metabolism
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinases / antagonists & inhibitors*
  • Cyclin-Dependent Kinases / metabolism
  • Indoles / chemistry*
  • Indoles / pharmacology
  • Protein Kinase Inhibitors / chemistry*
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins / antagonists & inhibitors
  • Proto-Oncogene Proteins / metabolism

Substances

  • Carbazoles
  • Indoles
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins
  • Cyclin D1
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinases